This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ANKTIVA®
Bladder Cancer Detection
CORE-001 Study
EV-302
Immunotherapy in NMIBC
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher® Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Urologic Catheters (Includes CAUTI)
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Actionable Clinical Data
Bladder Cancer
LG-IR NMIBC
Adstiladrin®
Kidney Cancer
ZIRCON
Trials in Progress
Trials in Progress
Bladder Cancer
BOND-003 Cohort P
CORE-008
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
AUA 2025
PSMA and Beyond 2025 Conference
EAU 2025
SES AUA 2025
Thought Leaders 2025
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Conferences
AUA 2014
AUA 2014 - Bladder Cancer
Recent Abstracts
#AUA14 - State-of-the-Art Lecture: Clinical implications of The Cancer Genome Atlas Project on muscle-invasive bladder cancer - Session Highlights
May 21, 2014
#AUA14 - Performance of primary radical cystectomy and risk of pathologic upstaging in patients with Stage I high grade urothelial carcinoma of the bladder: A National Cancer Database analysis - Session Highlights
May 21, 2014
#AUA14 - State-of-the-Art Lecture: Development of bladder cancer biomarkers - Session Highlights
May 20, 2014
#AUA14 - Poster: Performance of early radical cystectomy and risk of pathologic upstaging in patients with stage I high grade urothelial carcinoma of the bladder: A National Cancer Database analysis
May 19, 2014
#AUA14 - Do circulating tumor cells help in decision-making regarding adjuvant chemotherapy in patients with urothelial carcinoma of the bladder treated with radical cystectomy? - Session Highlights
May 19, 2014
#AUA14 - Differential gene expression in responsive versus recurrent non-muscle invasive high-grade urothelial carcinomas after induction BCG - Session Highlights
May 18, 2014
#AUA14 - The oxidative stress response of urothelial carcinoma cells to BCG exposure - Session Highlights
May 18, 2014
#AUA14 - Predicting response to bacillus Calmette-Guerin (BCG) - Session Highlights
May 18, 2014
#AUA14 - Neutrophil-to-lymphocyte ratio (NLR): Prognostic indicator for overall survival (OS) in patients undergoing radical cystectomy (RC) - Session Highlights
May 18, 2014
#AUA14 - Is extended pharmacological venous thromboembolism prophylaxis uniformly safe following radical cystectomy? - Session Highlights
May 18, 2014
#AUA14 - Poster: How safe is extended pharmacological venous thromboembolism prophylaxis (EPVTEP) following radical cystectomy?
May 18, 2014
#AUA14 - Treatment patterns in patients with recurrent high-risk bladder cancer - Session Highlights
May 16, 2014
#AUA14 - Evaluation of the ACS NSQIP Surgical Risk Calculator in patients undergoing radical cystectomy - Session Highlights
May 16, 2014
#AUA14 - Poster: Evaluation of the ACS NSQIP Surgical Risk Calculator in patients undergoing radical cystectomy
May 16, 2014
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free